Showing posts with label OGX-011. Show all posts
Showing posts with label OGX-011. Show all posts
Thursday, February 25, 2010
The European Medicines Agency is in Overall Agreement with OncoGenex Pharmaceuticals' Development Plan for OGX-011 - financial news
"Since increased clusterin production is observed in many human cancers, including prostate, non-small cell lung, breast, ovarian, bladder, renal, pancreatic, anaplastic large cell lymphoma and colon cancers and melanoma, OGX-011 may have broad market potential to treat many cancer indications and disease stages."
Subscribe to:
Posts
(
Atom
)
